Inovio Pharmaceuticals Revenue Growth & History (INO)

Inovio Pharmaceuticals reported $65,343 in revenue for fiscal 2025, a decrease of 69.99% from the previous fiscal year.

View full Inovio Pharmaceuticals company overview

Inovio Pharmaceuticals annual revenue and growth

Inovio Pharmaceuticals annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20252025-12-31$65,343−$152,413−69.99%
20242024-12-31$217,756−$614,254−73.83%
20232023-12-31$832,010−$9.4M−91.89%
20222022-12-31$10.3M$8.5M+478.23%
20212021-12-31$1.8M−$5.6M−76.05%
20202020-12-31$7.4M$3.3M+80.24%
20192019-12-31$4.1M−$26.4M−86.51%
20182018-12-31$30.5M−$11.7M−27.80%
20172017-12-31$42.2M$6.9M+19.37%
20162016-12-31$35.4M−$5.2M−12.83%
20152015-12-31$40.6M$30.1M+288.00%
20142014-12-31$10.5M−$3.0M−22.35%
20132013-12-31$13.5M$9.3M+226.98%
20122012-12-31$4.1M−$5.7M−57.95%
20112011-12-31$9.8M$3.7M+59.41%
20102010-12-31$6.1M−$3.0M−32.62%
20092009-12-31$9.1M
About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Primary source

SEC company filings

TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.

Review Inovio Pharmaceuticals filings at SEC.gov ↗